BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
28 hedge funds and large institutions have $2.78M invested in Baudax Bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
28
Holding in Top 10
–
Calls
$34K
Puts
–
Top Buyers
| 1 | +$1.02M | |
| 2 | +$152K | |
| 3 | +$26.8K | |
| 4 |
Renaissance Technologies
New York
|
+$24K |
| 5 |
VF
Virtu Financial
New York
|
+$10K |
Top Sellers
| 1 | -$90K | |
| 2 | -$54.6K | |
| 3 | -$32K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19.6K |
| 5 |
D.E. Shaw & Co
New York
|
-$18K |